Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.

ABSTRACT:

Introduction

Peripartum cardiomyopathy (PPCM) is a rare but potentially lifethreatening disease, defined as idiopathic cardiomyopathy occurring towards the end of pregnancy or in the months following delivery, abortion or miscarriage. We aim to raise awareness of this condition and give an overview of current knowledge as well as an insight and comparison of clinical trials focusing on randomized controlled trials.

Material and methods

Systematic literature searches were conducted using PubMed up to December 2021. Studies published involving clinical trials and interventions in women with PPCM after 1970 were selected.

Results

Randomized controlled trials have shown that the addition of Bromocriptine to standardized heart failure therapy improves outcome in terms of r

SUBMITTER: Mujkanovic J 

PROVIDER: S-EPMC10201896 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature